A Phase 2/3, Randomized, 3-Part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Protocol No
GI-REGENERON-ENGAGE
Staff Member
Patrick Sanvanson
Phase
II/III
Summary

This project is being done to study participants with active eosinophilic gastritis (EoG) with or without eosinophilic duodenitis (EoD).
Objective
Dupilumab for Eosinophilic Gastritis W WO Eosinophilic Duodenitis
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Other, Digestive System
ClinicalTrials.gov
https://www.clinicaltrials.gov/study/NCT05831176